Report Detail
Global Epoetin (Eritropoyetin) Market Insights, Forecast to 2025
- RnM3154081 |
- 20 March, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Epoetin (Eritropoyetin) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epoetin (Eritropoyetin) market based on company, product type, end user and key regions.
This report studies the global market size of Epoetin (Eritropoyetin) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epoetin (Eritropoyetin) in these regions.
This research report categorizes the global Epoetin (Eritropoyetin) market by top players/brands, region, type and end user. This report also studies the global Epoetin (Eritropoyetin) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
Epoetin
Abcam
Johnson & Johnson
Hospira Inc
Roche
LG Life Sciences Ltd
Biocon
Intas Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Ranbaxy Laboratories Ltd
Celltrion, Inc
Market size by Product
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Market size by End User
Anemia (Cancer and HIV treatment)
Kidney Disorders (ESRD and Dialysis)
Others (Neural Disease and Wound healing)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Epoetin (Eritropoyetin) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Epoetin (Eritropoyetin) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Epoetin (Eritropoyetin) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Epoetin (Eritropoyetin) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Epoetin (Eritropoyetin) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epoetin (Eritropoyetin) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Epoetin (Eritropoyetin) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Epoetin (Eritropoyetin) Market Size Growth Rate by Product
- 1.4.2 Epoetin-alfa
- 1.4.3 Epoetin-beta
- 1.4.4 Darbepoetin-alfa
- 1.5 Market by End User
- 1.5.1 Global Epoetin (Eritropoyetin) Market Size Growth Rate by End User
- 1.5.2 Anemia (Cancer and HIV treatment)
- 1.5.3 Kidney Disorders (ESRD and Dialysis)
- 1.5.4 Others (Neural Disease and Wound healing)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Epoetin (Eritropoyetin) Market Size
- 2.1.1 Global Epoetin (Eritropoyetin) Revenue 2014-2025
- 2.1.2 Global Epoetin (Eritropoyetin) Sales 2014-2025
- 2.2 Epoetin (Eritropoyetin) Growth Rate by Regions
- 2.2.1 Global Epoetin (Eritropoyetin) Sales by Regions
- 2.2.2 Global Epoetin (Eritropoyetin) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Epoetin (Eritropoyetin) Sales by Manufacturers
- 3.1.1 Epoetin (Eritropoyetin) Sales by Manufacturers
- 3.1.2 Epoetin (Eritropoyetin) Sales Market Share by Manufacturers
- 3.1.3 Global Epoetin (Eritropoyetin) Market Concentration Ratio (CR5 and HHI)
- 3.2 Epoetin (Eritropoyetin) Revenue by Manufacturers
- 3.2.1 Epoetin (Eritropoyetin) Revenue by Manufacturers (2014-2019)
- 3.2.2 Epoetin (Eritropoyetin) Revenue Share by Manufacturers (2014-2019)
- 3.3 Epoetin (Eritropoyetin) Price by Manufacturers
- 3.4 Epoetin (Eritropoyetin) Manufacturing Base Distribution, Product Types
- 3.4.1 Epoetin (Eritropoyetin) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Epoetin (Eritropoyetin) Product Type
- 3.4.3 Date of International Manufacturers Enter into Epoetin (Eritropoyetin) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Epoetin (Eritropoyetin) Sales by Product
- 4.2 Global Epoetin (Eritropoyetin) Revenue by Product
- 4.3 Epoetin (Eritropoyetin) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Epoetin (Eritropoyetin) Breakdown Data by End User
6 North America
- 6.1 North America Epoetin (Eritropoyetin) by Countries
- 6.1.1 North America Epoetin (Eritropoyetin) Sales by Countries
- 6.1.2 North America Epoetin (Eritropoyetin) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Epoetin (Eritropoyetin) by Product
- 6.3 North America Epoetin (Eritropoyetin) by End User
7 Europe
- 7.1 Europe Epoetin (Eritropoyetin) by Countries
- 7.1.1 Europe Epoetin (Eritropoyetin) Sales by Countries
- 7.1.2 Europe Epoetin (Eritropoyetin) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Epoetin (Eritropoyetin) by Product
- 7.3 Europe Epoetin (Eritropoyetin) by End User
8 Asia Pacific
- 8.1 Asia Pacific Epoetin (Eritropoyetin) by Countries
- 8.1.1 Asia Pacific Epoetin (Eritropoyetin) Sales by Countries
- 8.1.2 Asia Pacific Epoetin (Eritropoyetin) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Epoetin (Eritropoyetin) by Product
- 8.3 Asia Pacific Epoetin (Eritropoyetin) by End User
9 Central & South America
- 9.1 Central & South America Epoetin (Eritropoyetin) by Countries
- 9.1.1 Central & South America Epoetin (Eritropoyetin) Sales by Countries
- 9.1.2 Central & South America Epoetin (Eritropoyetin) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Epoetin (Eritropoyetin) by Product
- 9.3 Central & South America Epoetin (Eritropoyetin) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Epoetin (Eritropoyetin) by Countries
- 10.1.1 Middle East and Africa Epoetin (Eritropoyetin) Sales by Countries
- 10.1.2 Middle East and Africa Epoetin (Eritropoyetin) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Epoetin (Eritropoyetin) by Product
- 10.3 Middle East and Africa Epoetin (Eritropoyetin) by End User
11 Company Profiles
- 11.1 Amgen
- 11.1.1 Amgen Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Amgen Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Amgen Epoetin (Eritropoyetin) Products Offered
- 11.1.5 Amgen Recent Development
- 11.2 Epoetin
- 11.2.1 Epoetin Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Epoetin Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Epoetin Epoetin (Eritropoyetin) Products Offered
- 11.2.5 Epoetin Recent Development
- 11.3 Abcam
- 11.3.1 Abcam Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Abcam Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Abcam Epoetin (Eritropoyetin) Products Offered
- 11.3.5 Abcam Recent Development
- 11.4 Johnson & Johnson
- 11.4.1 Johnson & Johnson Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Johnson & Johnson Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Johnson & Johnson Epoetin (Eritropoyetin) Products Offered
- 11.4.5 Johnson & Johnson Recent Development
- 11.5 Hospira Inc
- 11.5.1 Hospira Inc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Hospira Inc Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Hospira Inc Epoetin (Eritropoyetin) Products Offered
- 11.5.5 Hospira Inc Recent Development
- 11.6 Roche
- 11.6.1 Roche Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Roche Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Roche Epoetin (Eritropoyetin) Products Offered
- 11.6.5 Roche Recent Development
- 11.7 LG Life Sciences Ltd
- 11.7.1 LG Life Sciences Ltd Company Details
- 11.7.2 Company Business Overview
- 11.7.3 LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 LG Life Sciences Ltd Epoetin (Eritropoyetin) Products Offered
- 11.7.5 LG Life Sciences Ltd Recent Development
- 11.8 Biocon
- 11.8.1 Biocon Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Biocon Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Biocon Epoetin (Eritropoyetin) Products Offered
- 11.8.5 Biocon Recent Development
- 11.9 Intas Pharmaceuticals
- 11.9.1 Intas Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Intas Pharmaceuticals Epoetin (Eritropoyetin) Products Offered
- 11.9.5 Intas Pharmaceuticals Recent Development
- 11.10 Teva Pharmaceutical Industries Ltd
- 11.10.1 Teva Pharmaceutical Industries Ltd Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Products Offered
- 11.10.5 Teva Pharmaceutical Industries Ltd Recent Development
- 11.11 Ranbaxy Laboratories Ltd
- 11.12 Celltrion, Inc
12 Future Forecast
- 12.1 Epoetin (Eritropoyetin) Market Forecast by Regions
- 12.1.1 Global Epoetin (Eritropoyetin) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Epoetin (Eritropoyetin) Revenue Forecast by Regions 2019-2025
- 12.2 Epoetin (Eritropoyetin) Market Forecast by Product
- 12.2.1 Global Epoetin (Eritropoyetin) Sales Forecast by Product 2019-2025
- 12.2.2 Global Epoetin (Eritropoyetin) Revenue Forecast by Product 2019-2025
- 12.3 Epoetin (Eritropoyetin) Market Forecast by End User
- 12.4 North America Epoetin (Eritropoyetin) Forecast
- 12.5 Europe Epoetin (Eritropoyetin) Forecast
- 12.6 Asia Pacific Epoetin (Eritropoyetin) Forecast
- 12.7 Central & South America Epoetin (Eritropoyetin) Forecast
- 12.8 Middle East and Africa Epoetin (Eritropoyetin) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Epoetin (Eritropoyetin) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Epoetin (Eritropoyetin) . Industry analysis & Market Report on Epoetin (Eritropoyetin) is a syndicated market report, published as Global Epoetin (Eritropoyetin) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Epoetin (Eritropoyetin) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
